This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes
by Zacks Equity Research
Revvity partners with Sanofi to launch a scalable diagnostic test for early T1D detection, expanding its reach beyond rare diseases.
SNYPositive Net Change MASINegative Net Change MMSIPositive Net Change RVTYPositive Net Change
medical medical-devices
CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions
by Moumi Mondal
CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.
HUMPositive Net Change CVSPositive Net Change CNCPositive Net Change
medical medical-devices
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
by Zacks Equity Research
ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
ECLPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change
medical medical-devices
PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell
by Zacks Equity Research
PACB expands seqWell partnership to enhance its sequencing workflow offerings with a new multiplexing kit.
RMDPositive Net Change MASINegative Net Change PACBNegative Net Change SOLVPositive Net Change
medical medical-devices
McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
by Zacks Equity Research
MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.
CAHPositive Net Change MCKNegative Net Change CORPositive Net Change
medical medical-devices
ISRG Bets on SP Platform to Capture Rising ASC Procedure Volume
by Indrajit Bandyopadhyay
Intuitive Surgical's SP platform is gaining traction as a cost-efficient, high-throughput option for ASCs, complementing da Vinci 5 in hospitals.
CNMDNegative Net Change ISRGPositive Net Change STEPositive Net Change
medical medical-devices
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation
by Moumi Mondal
HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.
HOLXNegative Net Change MYGNNegative Net Change QGENPositive Net Change
medical medical-devices
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
by Zacks Equity Research
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
CAHPositive Net Change MASINegative Net Change TECHNegative Net Change PAHCPositive Net Change
medical medical-devices
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System
by Zacks Equity Research
NYXH's first U.S. commercial use of its Genio system signals strong physician demand and sets the stage for broad adoption in sleep apnea care.
WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change NYXHNegative Net Change
medical medical-devices
Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock
by Zacks Equity Research
TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.
AZNPositive Net Change TMOPositive Net Change MASINegative Net Change PAHCPositive Net Change
medical medical-devices
CAH Expands Distribution Network With Indianapolis Facility
by Zacks Equity Research
Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.
CAHPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change
medical medical-devices
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
by Zacks Equity Research
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change ICCMNegative Net Change
medical medical-devices
How to Play HOLX Stock This Breast Cancer Awareness Month?
by Moumi Mondal
Hologic's breast health innovations, AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.
HOLXNegative Net Change QGENPositive Net Change GEHCNegative Net Change
medical medical-devices
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
by Zacks Equity Research
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
MASINegative Net Change AXGNNegative Net Change PAHCPositive Net Change CLPTNegative Net Change
medical medical-devices
Best Value Stocks to Buy for October 6th
by Zacks Equity Research
ELAN, DINO and EMBC made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 6, 2025.
ELANNegative Net Change DINOPositive Net Change EMBCPositive Net Change
medical-devices
Hims & Hers Expands Health Access Through Subscription Revenue Model
by Zacks Equity Research
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
MEDPositive Net Change AMWLPositive Net Change HIMSNegative Net Change
medical medical-devices
ILMN Stock Set to Benefit From the Launch of New BioInsight Division
by Zacks Equity Research
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.
ILMNPositive Net Change MASINegative Net Change PAHCPositive Net Change CRMDNegative Net Change
medical medical-devices
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
by Zacks Equity Research
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, sending shares higher.
ANGOPositive Net Change MASINegative Net Change PAHCPositive Net Change CRMDNegative Net Change
earnings medical medical-devices
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
by Zacks Equity Research
ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.
TMOPositive Net Change ILMNPositive Net Change MYGNNegative Net Change QGENPositive Net Change
medical medical-devices
Can Doximity's New AI Suite Drive the Growth It Needs?
by Indrajit Bandyopadhyay
DOCS reports stronger Q1 results and is betting on its new AI suite -- Scribe, GPT, and Pathway -- to drive its next growth phase.
CERTNegative Net Change DOCSNegative Net Change GEHCNegative Net Change
medical medical-devices
Nyxoah Expands in the Middle East to Provide Wider Access to Genio
by Zacks Equity Research
NYXH expands in the Middle East after Abu Dhabi's first Genio implant, aiming to broaden access for OSA patients.
RMDPositive Net Change LIVNPositive Net Change INSPNegative Net Change NYXHNegative Net Change
medical medical-devices
ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?
by Indrajit Bandyopadhyay
Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.
JNJNegative Net Change MDTPositive Net Change ISRGPositive Net Change
medical medical-devices
Is Veeva's Vault CRM Emerging as the Standard for Top Biopharma?
by Zacks Equity Research
VEEV's Vault CRM is gaining traction with top biopharma firms like Merck, Gilead, and BMS, signaling its rise as the industry's commercial standard.
CRMPositive Net Change VEEVPositive Net Change IQVNegative Net Change
medical medical-devices
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
by Zacks Equity Research
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.
BDXPositive Net Change BAXPositive Net Change MCKNegative Net Change OMCLNegative Net Change
medical medical-devices
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
by Moumi Mondal
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
BSXPositive Net Change SYKPositive Net Change HOLXNegative Net Change
medical medical-devices